Simplex Trading’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.7K | Sell |
7,300
-1,700
| -19% | -$3.15K | ﹤0.01% | 7121 |
|
|
2026
Q1 | $10.8K | Buy |
9,000
+3,100
| +53% | +$3.77K | ﹤0.01% | 7300 |
|
|
2025
Q4 | $5.8K | Buy |
5,900
+5,100
| +638% | +$6.12K | ﹤0.01% | 7346 |
|
|
2025
Q3 | $1K | Buy |
+800
| New | +$863 | ﹤0.01% | 8801 |
|
|
2024
Q4 | – | Sell |
-900
| Closed | -$3K | – | 8824 |
|
|
2024
Q3 | $3K | Buy |
900
+100
| +13% | +$389 | ﹤0.01% | 7829 |
|
|
2024
Q2 | $2K | Sell |
800
-500
| -38% | -$2.19K | ﹤0.01% | 8262 |
|
|
2024
Q1 | $9K | Buy |
+1,300
| New | +$8.05K | ﹤0.01% | 7669 |
|
|
2023
Q3 | – | Sell |
-14,900
| Closed | -$70K | – | 8979 |
|
|
2023
Q2 | $70K | Sell |
14,900
-9,000
| -38% | -$49.7K | ﹤0.01% | 5486 |
|
|
2023
Q1 | $136K | Buy |
23,900
+20,100
| +529% | +$121K | ﹤0.01% | 4792 |
|
|
2022
Q4 | $38K | Sell |
3,800
-2,100
| -36% | -$39.4K | ﹤0.01% | 6198 |
|
|
2022
Q3 | $132K | Buy |
5,900
+3,200
| +119% | +$92.5K | ﹤0.01% | 5140 |
|
|
2022
Q2 | $66K | Sell |
2,700
-2,200
| -45% | -$60.7K | ﹤0.01% | 6121 |
|
|
2022
Q1 | $189K | Buy |
4,900
+900
| +23% | +$34.9K | ﹤0.01% | 5231 |
|
|
2021
Q4 | $234K | Buy |
4,000
+3,200
| +400% | +$181K | ﹤0.01% | 4947 |
|
|
2021
Q3 | $75K | Hold |
800
| – | – | ﹤0.01% | 7011 |
|
|
2021
Q2 | $69K | Buy |
800
+785
| +5,233% | +$63.3K | ﹤0.01% | 7223 |
|
|
2021
Q1 | $123K | Buy |
15
+10
| +200% | +$958 | ﹤0.01% | 5445 |
|
|
2020
Q4 | $45K | Sell |
5
-10
| -67% | -$621 | ﹤0.01% | 6296 |
|
|
2020
Q3 | $59K | Sell |
15
-33
| -69% | -$1.15K | ﹤0.01% | 5445 |
|
|
2020
Q2 | $164K | Sell |
48
-498
| -91% | -$14.8K | ﹤0.01% | 4220 |
|
|
2020
Q1 | $1.21M | Sell |
546
-502
| -48% | -$12.7K | ﹤0.01% | 1705 |
|
|
2019
Q4 | $2.05M | Buy |
1,048
+309
| +42% | +$4.91K | ﹤0.01% | 1460 |
|
|
2019
Q3 | $1.15M | Sell |
739
-773
| -51% | -$14.8K | ﹤0.01% | 1800 |
|
|
2019
Q2 | $3.07M | Sell |
1,512
-18
| -1% | -$324 | 0.01% | 998 |
|
|
2019
Q1 | $2.69M | Buy |
1,530
+1,147
| +299% | +$18.1K | 0.01% | 1113 |
|
|
2018
Q4 | $491K | Sell |
383
-288
| -43% | -$4.02K | ﹤0.01% | 2254 |
|
|
2018
Q3 | $1.09M | Buy |
671
+131
| +24% | +$1.55K | ﹤0.01% | 1794 |
|
|
2018
Q2 | $612K | Buy |
540
+131
| +32% | +$1.44K | ﹤0.01% | 2256 |
|
|
2018
Q1 | $85K | Buy |
409
+359
| +718% | +$3.44K | ﹤0.01% | 1932 |
|
|
2017
Q4 | $8K | Buy |
50
+45
| +900% | +$201 | ﹤0.01% | 4089 |
|
|
2017
Q3 | $1K | Buy |
+5
| New | +$17 | ﹤0.01% | 5411 |
|
Other funds holding FATE
RG
JJ
Simplex Trading's FATE Position: Q2 2026 in Review
Simplex Trading reduced its Fate Therapeutics (FATE) stake by 70% in Q2 2026, selling an estimated $21.4K and leaving 4,866 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7465.
Simplex Trading first reported a position in FATE in Q3 2017 and has held it in 28 quarters since. The position peaked at $770K in Q3 2020. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.
- Simplex Trading held 4,866 shares of Fate Therapeutics worth $13.1K as of Q2 2026.
- Simplex Trading sold 11,570 Fate Therapeutics shares in Q2 2026, an estimated $21.4K.
- Fate Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7465 holding.
- Simplex Trading first reported a position in Fate Therapeutics in Q3 2017 and has held it in 28 quarters since.
- Simplex Trading's Fate Therapeutics position peaked at $770K in Q3 2020.
- 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.